重型急性脑损伤的血糖控制:系统评价与Meta分析及试验序贯分析
该系统评价纳入18项RCT(N=3196)和13项观察性研究(N=8354),比较ICU重型急性脑损伤患者严格与宽松血糖控制目标。固定效应Meta分析显示严格控糖对死亡率无影响(RR 0.95;95%CI 0.84-1.08;I2 0%;极低证据级别),对功能结局也无明确影响(N=1239;RR 0.91;95%CI 0.82-1.00;I2 0%;低证据级别),TSA提示功能结局方面证据已反对存在效应。无研究报告健康相关生活质量。
要点
- 18项RCT(N=3196)固定效应Meta分析:严格vs宽松控糖对死亡率无影响,RR 0.95(95%CI 0.84-1.08;I2 0%;极低证据级别)。
- 功能结局(N=1239)RR 0.91(95%CI 0.82-1.00;I2 0%;低证据级别),TSA提示证据反对存在效应。
- 死亡率TSA提示仍需额外试验,严格控糖获益仍不确定。
- 无研究报告健康相关生活质量,该结局无法评估。
- 证据确定性为低至极低,不能据此强制推行严格血糖控制目标。
适用人群与场景
- ICU收治的重型急性脑损伤患者(原文纳入RCT与观察性研究中比较血糖控制目标的人群)。
诊断标准与关键阈值
- 原文未提及具体血糖目标值或启动/停止阈值。
处置流程与药物剂量
- 原文未提及具体药物、剂量、给药途径或目标值。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:系统评价与Meta分析,含试验序贯分析(TSA)和GRADE证据分级。
- 纳入18项RCT(N=3196)和13项观察性研究(N=8354),检索29,221条记录。
- 主要终点死亡率:严格vs宽松控糖RR 0.95(95%CI 0.84-1.08;I2 0%;极低证据级别),TSA提示需额外试验。
- 功能结局:N=1239,RR 0.91(95%CI 0.82-1.00;I2 0%;低证据级别),TSA提示证据反对存在效应。
- 健康相关生活质量:无研究报告。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入RCT和观察性研究。
- 证据等级:GRADE分级,死亡率为极低证据级别,功能结局为低证据级别。
- 局限:原文未明确列出具体局限;证据确定性低至极低,死亡率TSA提示仍需额外试验。
对床旁实践的改变
- 低至极低确定性证据不支持在重型急性脑损伤ICU患者中常规采用严格血糖控制以改善死亡率或神经功能结局。
- 功能结局方面TSA提示证据反对存在效应,提示严格控糖未必带来功能获益。
- 原文未提供具体血糖目标值或药物方案,临床决策不能依据本证据确定阈值。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hyperglycemia is common in intensive care unit (ICU) patients, including those with acute brain injury. Although many studies associate hyperglycemia with increased mortality, the optimal blood glucose target remains uncertain. This systematic review compares strict versus liberal glycemic control in ICU patients with acute brain injury, focusing on all-cause mortality, neurological outcome, and health-related quality of life.
METHODS: Two authors independently searched CENTRAL, EMBASE, Medline, Web of Science, CINAHL, and trial registers for studies comparing glycemic control targets. Data were extracted in duplicate with discrepancies resolved by two screeners using Covidence. We performed meta-analysis, trial sequential analysis (TSA), and risk-of-bias assessment, and evaluated certainty of evidence using Grading of Recommendations Assessment, Development and Evaluation (GRADE).
RESULTS: From 29,221 records, we included 18 randomized clinical trials (RCTs) (N = 3196 patients) and 13 observational studies (N = 8354 patients). Fixed-effect meta-analysis suggested no effect on mortality from strict compared with liberal control (N = 3196 patients; RR 0.95; 95% CI 0.84-1.08; I2 0%; very low level of evidence), with TSA indicating a need for additional trials. Fixed-effect meta-analysis showed no clear effect on functional outcome (N = 1239 patients; RR 0.91; 95% CI 0.82-1.00; I2 0%; low level of evidence), and TSA indicated evidence against an effect. No studies reported health-related quality of life.
CONCLUSIONS: Low to very low certainty evidence suggests there is no difference between strict and liberal glycemic control regarding mortality or functional neurological outcome after severe acute brain injury. While additional large, low-bias RCTs could improve certainty, the benefit from strict glycemic control remains uncertain.
参考来源
- Fenger AW, Olsen MH, Jensen HR, et al. Glycemic Control in Severe Acute Brain Injury: Systematic Review and Meta-analysis with Trial Sequential Analysis. Neurocrit Care. 2026. PMID: 42477260. doi:10.1007/s12028-026-02592-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。